We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The 2024 GOLD report newly highlights hyperinflation, ...
Theory-based smoking cessation interventions helped to motivate patients with chronic obstructive pulmonary disease (COPD) who smoke to quit, ultimately improving their quality of life and lung ...
Researchers noted that the relationships between smoking, chronic obstructive pulmonary disease (COPD), and depression must be recognized to effectively manage the complicated care needs for this ...
In a population spirometric screening of 11,027 subjects who were at risk for COPD in 12 Polish cities, AL was detected in 30.6% of smokers who were > 39 years of age who had a smoking history of > 10 ...
How many times have you heard something like this from a patient? “Every time I try to stop smoking, I gain weight. I know how dangerous smoking is, but gaining weight is just as unhealthy.” "Smoking ...
SEATTLE and VANCOUVER, British Columbia, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Immediately ...
(MENAFN- GlobeNewsWire - Nasdaq) New data address critical treatment gap for millions of Americans with COPD who face unique smoking cessation challenges SEATTLE and VANCOUVER, British Columbia, Sept.
SEATTLE/VANCOUVER - Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company with a market capitalization of $144 million, announced Monday that cytisinicline significantly ...
The underdiagnosed and poor management of COPD exacerbations represents a missed opportunity to prevent patient deterioration through proactive treatment approaches. Chronic obstructive pulmonary ...
SEATTLE and VANCOUVER, British Columbia, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results